The import of peroxisomal matrix proteins is dependent on one of two targeting signals, PTS1 and PTS2. We demonstrate in vivo that not only the import of thiolase but also that of a chimeric protein consisting of the thiolase PTS2 (amino acids 1-18) fused to the bacterial protein P-lactamase is Pas7p dependent. In addition, using a combination of several independent approaches (two-hybrid system, co-immunoprecipitation, affinity chromatography and high copy suppression), we show that Pas7p specifically interacts with thiolase in vivo and in vitro. For this interaction, the N-terminal PTS2 of thiolase is both necessary and sufficient. The specific binding of Pas7p to thiolase does not require peroxisomes. Pas7p recognizes the PTS2 of thiolase even when this otherwise N-terminal targeting signal is fused to the C-terminus of other proteins, i.e. the activation domain of Gal4p or GST. These results demonstrate that Pas7p is the targeting signal-specific receptor of thiolase in Saccharomyces cerevisiae and, moreover, are consistent with the view that Pas7p is the general receptor of the PTS2. Our observation that Pas7p also interacts with the human peroxisomal thiolase suggests that in the human peroxisomal disorders characterized by an import defect for PTS2 proteins (classical rhizomelic chondrodysplasia punctata), a functional homologue of Pas7p may be impaired.
Introduction
The function of most proteins is dependent on their correct subcellular localization. Their transport to their sites of action involves the specific recognition of targeting signals within the primary structure of the proteins. These short amino acid sequences are recognized by specific receptors, which then initiate a series of steps leading to protein translocation through membranes. Only a few such receptors have been identified so far.
In the case of peroxisomes, an essential metabolic compartment in eukaryotic cells, two different, evolutionary conserved peroxisomal targeting signals (PTS 1 and PTS2) are known to direct proteins into the matrix of these organelles. PTS1 is found at the extreme carboxyterminus of many peroxisomal proteins and comprises the tripeptide SKL or variants thereof (for review, see Subramani, 1993) . This tripeptide was identified initially in firefly luciferase (Gould et al., 1987) and is necessary and sufficient to target proteins to peroxisomes in diverse organisms, such as mammals, plants, insects and yeasts (Gould et al., 1990 ; Keller et al., 1991) . Another subset of peroxisomal proteins possesses the amino-terminal PTS2. Sequence comparison of these proteins revealed the consensus RLX5HL within the first 30 amino acids (de Hoop and Ab, 1992; Rehling et al., 1996) . The amino-terminus containing this consensus is necessary and sufficient to direct otherwise cytosolic proteins to the peroxisomal matrix. This has been shown for peroxisomal thiolase of rat (Tsukamoto et al., 1994) and Saccharomyces cerevisiae (Erdmann, 1994; Glover et al., 1994a) as well as for glyoxysomal malate dehydrogenase of watermelon (van der Klei et al., 1993) . In addition, site-specific mutations in the PTS2 consensus impair peroxisomal import (Glover et al., 1994a; Gietl et al., 1994) .
The elucidation of the molecular mechanisms underlying these peroxisomal sorting processes is severely hampered by the lack of an efficient in vitro import system based on purified peroxisomes. Therefore, we started a combined genetic and biochemical approach in S.cerevisiae to identify the essential components for protein import. This approach has led to the identification of 15 pas (peroxisome assembly deficient) complementation groups by us and others (Erdmann et al., 1989; van der Leij et al., 1992; Elgersma et al., 1993) . Although the corresponding 15 PAS genes have been cloned, distinct functions have been proposed thus far only for the gene products of PAS7 and PASIO. Among the pas mutants of S.cerevisiae, pas7 and paslO are unique in showing only partial import deficiencies. In paslO cells, proteins with the PTS1 signal remain cytosolic while thiolase, a PTS2 protein, is imported correctly (van der Leij et al., 1993) . In contrast, pas7 cells show the opposite defect: thiolase is not imported but all PTS1 proteins are directed correctly to the peroxisomal matrix (Marzioch et al., 1994; Zhang and Lazarow, 1995) . In humans, the failure to import polypeptides into peroxisomes has lethal consequences (Lazarow and Moser, 1995) . Recently, the same partial import defects of either PTS1 or PTS2 proteins have been described for two out of 10 complementation groups in human fibroblast cell lines of patients suffering from peroxisomal diseases (Motley et al., 1994; Slawecki et al., 1995) . These diseases are the result of mutationis affecting peroxisomal structure and/or function. These partial import defects in yeast and humans suggested the existence of two independent import receptors, one that recognizes the PTS1 and a second one that binds to the PTS2.
The PASIO gene of S.cerevisiae (van der Leij et al., P.Rehling et aL 1993) and its homologues in two methylotrophic yeasts, PAS8 of Pichia pastoris (McCollum et al., 1993) and PER3/PAH2 of Hansenula polymorpha van der Klei et al., 1995) , as well as its human counterpart Fransen et al., 1995; Wiemer et al., 1995) , have been cloned. The P.pastoris Pas8 protein and its human homologue were shown to bind peptides with SKL at the carboxy-terminus preferentially over the same peptides without SKL Fransen et al., 1995; Wiemer et al., 1995) . The human gene can functionally rescue fibroblast cell lines having a PTS1 protein import deficiency Wiemer et al., 1995) . These results were taken as evidence that these genes encode the PTS1 receptor. This interpretation was supported by studies using the twohybrid system which indicated that PaslOp of S.cerevisiae interacts with luciferase in a SKL-dependent manner (Brocard et al., 1994) . In addition, Fransen et al. (1995) Marzioch et al., 1994; Zhang and Lazarow, 1995) .
We have described previously the cloning of the S.cerevisiae PAS7 gene and the partial characterization of its gene product Pas7p (Marzioch et al., 1994) . The majority of the Pas7 protein was recovered in the cytosolic fraction, only a minor portion segregated in density gradients with peroxisomes and then only in cells which possess thiolase. Based on these results, we proposed that Pas7p binds thiolase (Fox3p) in the cytosol and might shuttle between the cytosol and the peroxisomal compartment in performing its function as the putative PTS2 receptor. In contrast, Zhang and Lazarow (1995) who also reported the cloning and sequencing of the same gene, which they termed PEBI, found Pas7p/Peblp in the peroxisomal matrix. They discussed a chaperone (Hsp7O)-like function for this protein.
In accordance with our shuttle model, we report here the first evidence that Pas7p binds thiolase both in vivo and in vitro and that this interaction is PTS2 dependent. Thus, Pas7p possesses the characteristics expected of a PTS2 receptor.
Results
Import of a PTS2-,8-Iactamase fusion protein into peroxisomes requires Pas7p
It had been shown that peroxisomal import of thiolase in S.cerevisiae is strictly dependent on Pas7p (Marzioch et al., 1994 (Erdmann, 1994; Glover et al., 1994a) , were fused to ,-lactamase lacking its own amino-terminal targeting signal required for secretion from bacteria. This reporter protein has been shown to be cytosolic in yeast in the absence of added targeting information (data not shown). Moreover, this bacterial protein has been used successfully for targeting studies in the methylotrophic yeast H.polymorpha (Waterham et al., 1994; Faber et al., 1995) . The PTS2-p-lactamase fusion protein was placed under control of the thiolase/FOX3 promotor (Einerhand et al., 1991) Figure  2B , a significant amount of the fusion protein co-migrated with the peroxisomal marker catalase and also tails into less dense fractions which most likely contain 'lighter' peroxisomal structures (Fox3p) in vivo, the GALA-based two-hybrid system was employed as a direct assay of protein-protein interaction (Fields and Song, 1989; Chien et al., 1991 Using the same approach, we investigated whether Pas7p was capable of binding to the human peroxisomal thiolase (Bout et al., 1988 (Figure 2A ).
Thiolase associates with Pas7p in vitro As an independent confirmation that Pas7p and thiolase specifically interact, the ability of Pas7p to precipitate thiolase from a crude extract was tested. Cells of the wildtype strain UTL-7A and Apas7 were transformed with the multicopy plasmid YEpmycP7 (Marzioch et al., 1994) . This plasmid encodes the full-length Pas7p with a myc epitope-tag at its amino-terminus under the control of the CUPI-promotor. The transformants were grown and crude extracts prepared (see Materials and methods). Immuno- Extracts were made from double transformants expressing various plasmid combinations and assayed for P-galactosidase fB-lactamase and thiolase activity. Untransformed PCY2 cells showed a 3-galactosidase activity of 1.1 nkat/mg protein and no measurable thiolase or 3-lactamase activity. PCY2 cells transformed with pCLI (Fields and Song, 1989) showed no measurable thiolase or f-lactamase activity but a 3-galactosidase activity of 147 541 nkat/mg protein.
precipitation of the myc-tagged Pas7p was performed by the use of monoclonal a-myc antibodies (9E10) bound to a-mouse IgG magnetic beads (Dynal). After washing of immunocomplexes, bound proteins were eluted from the beads with Laemmli sample buffer and subjected to denaturating electrophoresis and blotting. While no ax-myc-precipitable proteins were isolated from extracts of untransformed strains ( Figure 4A , lanes 1 and 3), the precipitates obtained from the transformants showed a 45 kDa protein band on Coomassie-stained SDS-PAGE ( Figure 4A , lanes 2 and 4). The 53 and 30 kDa polypeptides observed in all lanes correspond to the heavy and light chain of the monoclonal a-myc and amouse antibodies; the appearence of the additional 50 and 80 kDa proteins is due to the a-mouse IgG antibodies (data not shown). a-Myc ( Figure 4B , lanes 2 and 4) and a-Pas7p antibodies ( Figure 4C , lanes 2 and 4) as well as a-thiolase antibodies ( Figure 4D ) immunodecorated a band of~45 kDa in immunoprecipitates of transformed cells. This band was not observed in the controls (untransformed strains). Since the calculated molecular mass of mycPas7p (44.4 kDa) and thiolase (44.7 kDa) is almost identical, we conclude that both proteins co-immunoprecipitated as the 45 kDa band. These data confirm that Pas7p interacts tightly and specifically with thiolase in solution. Interaction of Pas7p and thiolase does not require functional peroxisomes.
In order to investigate whether the Pas7p-thiolase interaction requires import-competent peroxisomes, coimmunoprecipitation of these proteins was tested in type 1 pas mutants (Hohfeld et al., 1992) . These mutants contain no morphologically detectable peroxisomes. This experiment was performed withfox3-2A, Apas2 and Apas6 cells that had been transformed with plasmid YEpmycP7. In all immunoprecipitates the 45 kDa band was visible ( Figure 5A , lanes 1, 2 and 3) and could be immuno- Fig. 3 . Analysis of Pas7p interaction with either S.cerevisiae thiolase (Fox3p) or human peroxisomal thiolase in a two-hybrid system by means of HIS3 activation. Gal4-DB fusions (in vector pPC86) and Gal4-AD fusions (in pPC97) were transformed into yeast strain HF7c. Double transformants were selected on SD plates lacking leucine and tryptophan and replica plated on SD plates lacking leucine, tryptophan and histidine to assay for histidine prototrophy. Plates were incubated at 30°C for 3 days. Lanes 1, 2 and 3 represent three independent double transformants.
decorated by either a-myc or a-Pas7p antibodies. When the fox3-2A mutant defective in the gene for thiolase (Marzioch et al., 1994) was transformed and used as a source of cell extract no Fox3p co-immunoprecipitated with mycPas7p ( Figure SD, lane 1) . This result demonstrates the specificity of the antibodies used and shows that the 45 kDa band detected by a-thiolase antibodies ( Figures 4D and SD) is indeed the Fox3 polypeptide. The Apas2 mutant is biochemically characterized by residual peroxisomal membrane structures that fail to import matrix enzymes in contrast to Apas6 mutant cells in which no peroxisomes or peroxisomal membrane structures have been detected (Kunau et al., 1993) . protein and GST alone were expressed in Escherichia coli and purified by affinity chromatography. mycPas7p was isolated by immunoprecipitation from fox3-2A cells. Aliquots of the Dynabeads to which mycPas7p was bound via a-myc antibodies were incubated separately with equivalent amounts of either GST-PTS2 or GST alone. After washing of the immunocomplex and reprecipitation, bound proteins were separated by SDS-PAGE and analysed by Western blot using a-Pas7p antibodies ( Figure  7 ). Since these antibodies were raised against a GSTPas7p fusion protein, they recognize GST as well as mycPas7p. When mycPas7p was incubated with GST, only the mycPas7p was detected on the blot ( Figure 7 , lane 2). In contrast, when mycPas7p was incubated with GST-PTS2, both proteins were present in the precipitate (Figure 7 , lane 1). From these results, it can be concluded that Pas7p binds specifically to the PTS2 of thiolase even when this sequence is fused to GST, and that the N-terminal myc tag of Pas7p will not prevent its binding to thiolase.
Pas lOp, the PTS1 receptor and Pas7p interact in a two-hybrid system It has been reported that tetratricopeptide repeat (TPR) proteins (Lamb et al., 1995) and WD-40 proteins (Neer et al., 1994) are functionally related (Goebl and Yanagida, 1991; van der Voom and Ploegh, 1992) . Thus, we wanted to know whether Pas7p, which is a member of the WD-40 family, and PaslOp, which belongs to the TPR family and is thought to be the S.cerevisiae PTS1 receptor, can physically interact. Using the GAL4 two-hybrid system, it could be shown that double transformants carrying plasmids encoding DB-Pas7p and AD-PaslOp showed transcriptional activation of the reporter genes HIS3 ( Figure 8A ) and LacZ ( Figure 8B ), suggesting that these two proteins do indeed associate. Furthermore, this inter- (Figures 1 and 2) , the two-hybrid system (Table I) and the observation that overexpression of PAS7 from a multicopy vector suppressed the ts phenotype of a mutant allele of the PTS2 (Figure 6 ).
The co-immunoprecipitation (Figures 4 and 5 ) and in vitro binding data (Figure 7) argue against a merely transient interaction between Pas7p and the PTS2 and suggest a tight binding such as might be required for Pas7p to shuttle the PTS2 protein through the cytosol to the peroxisomal membrane. However, this interpretation also requires a mechanism for releasing the PTS2 protein from Pas7p when it has reached the peroxisome. It is conceivable that this is achieved by a conformational change of Pas7p caused by binding to a putative docking protein.
The finding that a targeting signal is recognized by a cytosolic protein which subsequently participates in a docking event at the membrane to be passed through is not without precedent. A number of similar events have been described, among them SRP binding to signal sequences of eukaryotic proteins targeted for secretion (Kurzchalia et al., 1986) , Sec B/Sec A interacting with prokaryotic signal sequences of proteins to be excreted (Randall and Hardy, 1995; Watanabe and Blobel, 1995) , nuclear targeting receptors such as importin recognizing nuclear targeting sequences (Powers and Forbes, 1994) and mitochondrial import 'factors' binding to mitochondrial targeting sequences (Murakami and Mori, 1990; Hachiya et al., 1994) .
A docking protein for the Pas7p-thiolase complex at the peroxisomal membrane has yet to be identified. The available genetic evidence, in the form of pas mutant phenotypes, does not favour the possibility that such a putative docking protein would be specific for the PTS2 import pathway. Only one complementation group with a partial import defect of PTS2 proteins exists among the human fibroblast cell lines from patients with peroxisomal disorders and among the yeast pas mutants. It is conceivable that a docking protein could serve for both the PTS1 and the PTS2 receptor pathways. In this case, all of the known PAS membrane proteins are candidates for such a function.
An especially important aspect of the two-hybrid experiments is the possibility that Pas7p binds thiolase in a folded state. This is suggested by the fact that the fusion protein of the Gal4 activating domain and thiolase showed thiolase activity. The recently established crystal structure of dimeric thiolase showed that the first 27 amino acids of both amino-termini protrude from the determined threedimensional structure and should, therefore, be easily accessible (Mathieu et al., 1994) . Moreover, the conclusion that Pas7p binds an active thiolase dimer helps to explain the recent, unexpected results of 'piggy-back experiments' (Glover et al., 1994b; McNew and Goodman, 1994) . In these experiments, truncated thiolase molecules lacking the amino-terminal PTS2 sequence could be translocated into peroxisomes only in conjunction with wild-type PTS2 containing thiolase. Recognition and binding of the PTS2 signal on the wild-type member of a mixed thiolase dimer might be sufficient to initiate translocation of both subunits. The binding of oligomeric thiolase to Pas7p would not necessarily mean that oligomeric proteins are translocated through the peroxisomal membrane; however, in the light of the recent report that the attachment of a PTS1 (SKL signal) can facilitate the transport of gold particles with diameters up to 9 nm into peroxisomes (Walton et al., 1995) , one will have to take such a possibility into account. It is of course possible that the import of matrix proteins into peroxisomes involves an entirely different as yet unknown mechanism.
Our results clearly demonstrate that Pas7p specifically interacts with the PTS2 of thiolase. However, this does not exclude an additional interaction between Pas7p and the remaining major part of thiolase. This possibility is suggested by the observation that, in comparison with wild-type thiolase, PTS2-,-lactamase shows not only a weaker interaction with Pas7p in the two-hybrid system but is also less efficiently imported into peroxisomes in vivo. It is possible that the PTS2 is bound by Pas7p with high affinity and that the resulting complex is stabilized by additional low affinity binding sites between the proteins.
It is interesting to note that the amino-terminus of PTS2
proteins with their consensus within the first 20-30 amino acid residues can be extended by a large number of additional amino acid residues and still be recognized by Pas7p. This conclusion was suggested by the nature of the thiolase-Gal4 fusion protein which was used in this study. In this construct, thiolase was fused via its aminoterminus to the carboxy-terminus of the Gal4 activation domain. It had been reported that the PTS2 consensus of mammalian thiolase is not at the extreme amino-terminus and thus can be considered an internal targeting signal (Swinkels et al., 1991) . Our results show that the PTS2 consensus can be moved much further away from the amino-terminus and still function correctly. This suggests that if the PTS2 binds to a pocket within Pas7p, it might actually interact as a hairpin rather than a straight stretch of amino acids. However, the PTS2 could also form a surface-surface interaction with Pas7p, as has been shown for some protein-peptide interactions (Stanfield and Wilson, 1995) . Taken together, the findings presented here demonstrate that Pas7p has all the properties expected of a cytosolic PTS2 receptor. We have thus substantiated experimentally the first step of the proposed shuttle mechanism (Marzioch et al., 1994) in which Pas7p starts thiolase import by specific binding to the PTS2. The identity of the protein and/or lipid which functions as the predicted binding site for this complex at the peroxisomal membrane must now be determined.
Our results do not rigorously exclude a second proposed function of Pas7p. Zhang and Lazarow found Pas7p entirely inside peroxisomes and proposed that this protein may be an intraorganellar receptor for thiolase which, by analogy to the mitochondrial Hsp7O and BiP, pulls thiolase into the peroxisome and/or contributes to the folding of thiolase within the organelle (Zhang and Lazarow, 1995) . However, this mode of action would require an as yet unknown extra-peroxisomal PTS2 receptor for which there is no evidence in any of the several extensive genetic screens which have been conducted in several laboratories. In addition, the construct used by Zhang and Lazarow (a triple HA tag fused to the C-terminus of Pas7p) might have resulted in an unphysiological localization. For example, if one assumes that Pas7p shuttles thiolase not only to but also through the peroxisomal membrane, one could envisage that the C-terminal HA tag might interfere with the exit of Pas7p. This would result in an entirely peroxisomal localization of Pas7p and, in addition, one would expect a somewhat less efficient growth on oleate due to cytosolic depletion. This is exactly what Zhang and Lazarow reported. In fact, our results of subperoxisomal fractionation of that part of Pas7p which is associated with peroxisomes suggested that peroxisomal Pas7p is partly membrane bound (peripheral and integral) and behaves partly as if it were soluble in the matrix. In addition, the PTS2-specific binding of thiolase by Pas7p argues against a chaperone-like function of the latter, since neither mitochondrial Hsp7O nor BiP specifically bind targeting sequences.
The PTS1 receptor has been identified in both yeast and humans. For these proteins, too, there are conflicting reports of intracellular localization, ranging from predominantly cytosolic Wiemer et al., 1995) to entirely membrane bound (Fransen et al., 1995; Terlecky et al., 1995) . The shuttle mechanism first proposed by us for Pas7p has also been adopted to explain the role of the PTS1 receptor in H.polymorpha (van der Klei et al., 1995) and humans Wiemer et al., 1995) .
Our finding that Pas7p interacts with PaslOp, the PTS1 receptor of S.cerevisiae, in the two-hybrid system is particularly interesting. Although genetic evidence clearly demonstrates that the two PTS-specific import pathways in S.cerevisiae are independent of each other (van der Leij et al., 1993; Marzioch et al., 1994; Zhang and Lazarow, 1995) , this observation may indicate that the import complex docking to the peroxisomal membrane contains more components than previously anticipated. In this respect, it is important to note that two patients with mutations in the PTS1 receptor exhibit different phenotypes. One patient has a partial import defect restricted to PTS 1 proteins while the other one mislocalizes both PTS 1 and PTS2 proteins Wiemer et al., 1995) . The physiological significance of our findings in the two-hybrid system is currently being investigated.
The fact that Pas7p recognizes not only the PIS2 of yeast thiolase but also human thiolase suggests conservation of the peroxisomal protein import machinery between yeast and human. It supports the hypothesis that not only peroxisomal targeting signals but also the receptor machinery may be conserved between lower and higher eukaryotes. Moreover, it provides a molecular explanation for the same partial import deficiencies for PTS1 and PTS2 proteins found among peroxisomal yeast mutants and fibroblast cell lines from patients with peroxisomal disorders (Motley et al., 1994; Slawecki et al., 1995) . On the basis of the present results and in view of the fact that the PTS2 consensus is highly conserved among PTS2 proteins (de Hoop and Ab, 1992; Rehling et al., 1996) , it seems very likely that Pas7p homologues will exist in other species of yeast and higher eukaryotes and will function there as the general PTS2 receptor.
Materials and methods

Strains and general methods
Genotypes of yeast strains used in this study are as follows: UTL-7A is MATa, ura3-52, leu2-3/112, trpl (W.Duntze, Bochum); Apas2 is MATa, pas2::LEU2, ura3-52, trpl (Wiebel and Kunau, 1993) ; Apas6 is MATa, pas6::LEU2, ura3-52, trpl ; Apas7 is MATa, pas7::LEU2, ura3-52, trpl (Marzioch et al., 1994) ; fox3-2A is MATo, fox3-2, ura3-52, leu2-3/112, trpl, ade2 (Marzioch et al., 1994) ; PCY2 is MATca, Agal4, Agal80, URA3::GALJ-lacZ, Ivs2-801nmber his3-A200, trpl-A63, leu2, ade2-0JO"'hre (Chevray and Nathans, 1992) ; HF7c is MATa, LYS2 ::GALI-HIS3, URA3::(GAL4 17mers)3-CYCJ-lacZ (Clontech) .
Common recombinant DNA techniques, including enzymatic modifications of DNA, fragment purification, bacterial transformation and plasmid isolation were performed essentially as described by either Maniatis et al. (1982) or Ausubel et al. (1989) . All yeast transformations (except for introduction of the two-hybrid vectors into strain HF7c) were done by the method of Gietz and Sugino (1988) . Total protein was measured by the BCA method (Pierce) using bovine serum albumin (BSA) as standard.
Cloning procedures
The oligonucleotides used are listed in Table II. A 801 bp SmaI-HindIll fragment coding for bacterial 3-lactamase lacking its N-terminal targeting signal (Faber et al., 1995) was ligated to similarly digested pEMBLyex4 (Mauri et al., 1993) , creating pPR6/ 70. Both the FOX3 promotor and the 5' 54 bp of the FOX3 open reading frame encoding the PTS2 were amplified by PCR using the oligonucleotides P1 and P2 and pRE156 (Erdmann, 1994) (Zaret and Sherman, 1982) into the BamHIKpnI-digested CEN vector YCplac33 (Gietz and Sugino, 1988) , resulting in YCpfPTS2-)-lac .
Construction of the PTS2 mutant FOX3 allele (arginine at position 4 replaced by glycine) was carried out using the Altered SitesTM in vitro P.Rehling et al. 5'-ATGTCTCAAGAACTACAAA-3' mutagenesis system (Promega). For this purpose, the FOX3 gene was isolated from pRE156 (Erdmann, 1994) , subcloned into pSELECT-I and mutagenized using primer NIS2 according to the manufacturer's protocol. The mutagenized allele subsequently was introduced into YEp352 (Hill et al., 1986 ) that contained the cvcl termination sequence (pFN3/8). Plasmid pWS-2 was constructed by introducing the FOX3 open reading frame and 227 bp promotor from pRE156 (Erdmann, 1994) into YEp352 with the cvcl termination sequence 3' of the gene.
For expression of Pas7p from a plasmid with the LEU2 marker gene, an XbaI-SmaI fragment was excised from pRSP7/1.2 (Marzioch et al., 1994) , comprising the PAS7 open reading frame, a 53 bp upstream and a 81 bp downstream region of the gene, and subsequently cloned into YEp351 (Hill et al., 1986) resulting in pPR7/4.
The first 18 amino acids comprising the PTS2 of Fox3p were fused to the C-terminus of GST by amplifying the PTS2-encoding 54 bp of FOX3 using primers KU3 and P2 and pRE156 as a template. After cloning of the PCR fragment into pUC1 8 using the primer-derived SmaI and EcoRI sites, the fragment was excised with BamHI and EcoRI and subsequently introduced into pGEX-4T3 (Pharmacia). Antibodies Anti-myc monoclonal antibodies (9E10) were a kind gift of M.Eilers (Heidelberg). Anti-thiolase (Fox3p) and anti-Pas3p antibodies were as reported (Erdmann and Hohfeld et al., 1991, respectively) . Polyclonal antibodies against f-lactamase were kindly provided by R.Roggenkamp (Dusseldorf, Germany).
The PAS7 gene was amplified by PCR using plasmid SK+P7/1.2 and primer MM 1 (Marzioch et al., 1994) and universial primer oligonucleotide, respectively. The PCR product was digested with BgIII and EcoRI, cloned into pGEX-4T-1 (Pharmacia) and digested with BamHI and EcoRI, creating pHS7G. This fuses the N-terminal 195 amino acid residues of Pas7p to GST, under control of the tac promotor. The fusion protein was expressed in and purified from Ecoli TG1, according to the manufacturer's instructions (Pharmacia).
Rabbit polyclonal antibodies to were produced by Eurogentec (Seraing, Belgium) according to standard methods (Harlow and Lane, 1988) . Antisera were tested initially for their ability to react in Western blots to the GST-Pas7 (1-195) fusion protein that was present in whole cell extracts of Ecoli TG I transformed with pHS7G.
Antibodies were affinity purified by binding to nitrocellulose derivatized with GST-Pas7p (1-375) fusion protein. The gene encoding this fusion protein was constructed by digestion of pHS7G with BamHI and SmaI and insertion of a BamHI-SmaI PAS7 fragment excised from plasmid SK+P7/1.2, resulting in plasmid pPR7/7 encoding a fusion of GST with the full-length Pas7p.
Nitrocellulose pieces with immobilized GST-Pas7p (1-375) fusion protein were incubated for 30 min at 30°C with antiserum against the Yaffe and Schatz (1984) .
Western blotting
Proteins were separated by electrophoresis and transferred to nitrocellulose according to Harlow and Lane (1988) . Protein-antibody complexes were visualized either by treatment with alkaline phosphatase colour developing reagents (Blake et al., 1984) or enhanced chemiluminescence (ECL, Amersham).
Electron microscopy and immunocytochemistry
Methods for the preparation of cells for electron microscopy have been described by Erdmann et al. (1989) . Immunocytochemical experiments were performed on ultrathin sections of Lowicryl-embedded cells, using specific antibodies against 3-lactamase as described by Douma et al. (1985) .
Subcellular fractionation and enzyme assays
Yeast lysates were prepared and fractionated by differential centrifugation as described earlier (Erdmann et al., 1989) . Further subfractionation by isopycnic sucrose density gradient centrifugation was performed by loading cell lysates onto a continuous 20-53% sucrose density gradient. Centrifugation, fractionation of the gradient and preparation of samples were carried out according to Hohfeld et al. (1991) .
Hypotonic lysis of organelle preparations with 10 mM Tris-HCI pH 8.0 and carbonate extraction of peripheral membrane proteins with 0.1 M Na2CO3, pH 11.5 were performed according to Crane et al. (1994) . P-Lactamase was assayed as described (Cartwright et al., 1994) using PADAC (CalBiochem) as substrate. Acetyl-CoA acyltransferase (3-oxoacyl-CoA thiolase; EC 2.3.1.16), catalase (EC 1.11.1.6.) and fumarate hydratase (fumarase; EC 4.2.1.2) were assayed as described by Moreno de la Garza et al. (1985) and Veenhuis et al. (1987) .
For quantitative studies of f-galactosidase activity, yeast strains were grown on 0.3% SD medium to stationary phase. Equal amounts of cells (500 mg) were resuspended in 500 gl of H buffer [10 mM Tris-HCI pH 7.4, 1 mM EDTA, 0.5 mM EGTA, 0.5 mM dithiothreitol (DTT), 0.5 mM benzamidine and 1.2 mM phenylmethylsulphonyl fluoride (PMSF)]. The cells were disrupted by vortexing for 6 min (12X30 s) using 0.5 mm glass beads. Homogenates were clarified by centrifugation at 26 000 g. The supernatant was used subsequently for the assay (Rose et al., 1990 ).
Co-immunoprecipitation
Yeast cells were grown on 0.3% SD medium to late log phase and subsequently for 15 h in YNOG (0.1% glucose, 0.1% oleic acid, 0.05% Tween 40, 0.1% yeast extract and 0.67% yeast nitrogen base). Induction of the CUPI promotor was performed with 0.025 g/l CUS04 according to Marzioch et al. (1994) . The cells were washed with dH2O and stored at -70°C. For each immunoprecipitation experiment, 0.8-1.0 g of cells were used. Three ml of solution A (50 mM Tris-HCI, pH 7.5, 50 mM NaCI, 0.2% Triton X-100), protease inhibitors [0.02% PMSF (Serva), 15 ,ug/ml bestatin, 1.5 ,ug/ml pepstatin, I ,ug/ml leupeptin, 0.1 tg/ml chymostatin (Boehringer Mannheim)] and 3 g of glass beads (0.5 mm) were added to the cells. Breakage was achieved by vortexing for 4 min (8X30 s with breaks of at least 30 s on ice) (Lamb et al., 1994) . Samples were filtered through cotton wool and liquid was transferred to Corex tubes and centrifuged at 35 000 g for 30 min. Extracts normalized for protein and volume were added to 5 1g of a-myc IgG (9E10) bound to sheep a-mouse IgG Dynabeads (Dynal) and incubated for 2 h at 40C. Samples were washed three times with I ml of solution A and subsequently resuspended in 60 gl of Laemmli sample buffer.
Preparation of anti-myc antibodies bound to anti-mouse IgG Dynabeads was accomplished as follows: per immunoprecipitation, 50 ,u of anti-mouse IgG Dynabeads were blocked with 5% BSA in phosphate-buffered saline (PBS) buffer for 2 h, washed five times with 10 vol of PBS and saturated with anti-myc ascites fluid (9E10) at 4°C overnight. The supernatant was removed, beads were washed five times with I ml of solution A, resuspended in 50 ,iu of solution A and subsequently used for the precipitation experiment.
Two-hybrid plasmids and assays
The PAS7 open reading frame (+ I to + 1128) was amplified from pRS7/ 1.2 (Marzioch et al., 1994) with the upstream primer KUI and the downstream primer KU2. The resulting PCR fragment was cloned into the C/aI and BamnHI site of pBluescript SK+ (Stratagene) by using the primer-derived Clal and BclI sites, resulting in pEWI. To avoid errors due to Taq polymerase, the 586 bp PAS7 internal EcoRV-HindIII fragment was repaced by the wild-type sequence and flanking regions were sequenced. The PAS7 fragment was isolated by using the vector Sall and Sacl site and subsequently cloned into the GAL4 DNA binding domain vector pPC86 (Chevray and Nathans, 1992) and GAL4 activation domain vector pPC97 (Chevray) .
The entire FOX3 open reading frame was amplified by PCR from pRE156 (Erdmann, 1994) using KU3 as sense primer and KU5 as antisense primer. To give rise to a FOX3 truncated of the PTS2 primers, KU4 and KU5 were used. The PCR products were cloned into pBluescript SK+ using the primer-derived Sall and BclI sites. Further cloning of both inserts was performed by SalI-SacI digestion and introduction of the fragments into pPC86 and pPC97.
To generate GAL4 DNA binding domain fusions and GAL4 activating domain fusions of f-lactamase and PTS2-J-lactamase in vectors pPC97 and pPC86, f-lactamase was amplified via PCR using El and E2 primer from pPR6/68 and PTS2-p-lactamase by using KU4 and E2 primers and pFN-3/12 as template. PCR products were cloned into pBluescript SK+ via the Sall and Sacl sites that had been introduced into the primers. The same fragments were taken from the pBluescript SK+ constructs and subsequently ligated into the pPC vectors. pPR6/68 contained a mutagenized ,B-lactamase (Faber et al., 1995) gene with an XbaI site following the C-terminal coding region in pBluescript II SK+.
In order to clone the human peroxisomal 3-oxoacyl-CoA thiolase into pPC86, the open reading frame was amplified from a human cDNA library (Clonetech) by using the primers KU47 and KU48. After subcloning of the PCR product into pEW I using the SmaI and SacI sites that had been introduced into the primers and thus replacing the PAS7 insert, further cloning was performed by isolating the thiolase cDNA insert from pBluescript SK+ by Sal-Sacl digestion and ligation of the fragment into pPC86.
The PAS1O fused to the GAL4 activation domain in pPC86 (Elgersma et al., 1995) was kindly provided by H.Tabak.
For transforming the yeast strain HF7c (Clonetech), we followed the Matchmaker protocol supplied by the manufacturers. Double transformants were selected on SD medium lacking tryptophan and leucine. Colonies were transfered to a nitrocellulose filter which was immersed in liquid nitrogen for 10-20 s. The filters were allowed to come to room temperature, then placed on top of Whatmann 3MM paper that had been soaked with 100 mM KPi pH 7.0 containing 1 mg/ml X-Gal. Filters were incubated for 30 min to overnight at 30°C.
To assay for the expression of HIS3 as an additional reporter in strain HF7c, cells were transferred to SD plates lacking tryptophan, leucine and histidine but containing 10 mM 3-aminotriazole.
In vitro binding assay
For the in vitro binding assay, GST and GST-PTS2 were isolated from E.coli TGI by affinity purification on glutathione-Sepharose 4B according to the manufacturer's instructions.
The mycPas7p was expressed in and isolated from fox3-2A cells by immunoprecipitation (see above) using Dynabeads and anti-myc antibodies. After extensive washing with solution A, the beads were incubated with either GST or GST-PTS2 for 2 h at 4°C. Beads were reprecipitated, washed with solution A and subsequently subjected to denaturating SDS-PAGE and Western blotting.
